Curcumin promotes AApoAII amyloidosis and peroxisome proliferation in mice by activating the PPARα signaling pathway

Abstract

Curcumin is a polyphenol compound that exhibits multiple physiological activities. To elucidate the mechanisms by which curcumin affects systemic amyloidosis, we investigated amyloid deposition and molecular changes in a mouse model of amyloid apolipoprotein A-II (AApoAII) amyloidosis, in which mice were fed a curcumin-supplemented diet. Curcumin supplementation for 12 weeks significantly increased AApoAII amyloid deposition relative to controls, especially in the liver and spleen. Liver weights and plasma ApoA-II and high-density lipoprotein concentrations were significantly elevated in curcumin-supplemented groups. RNA-sequence analysis revealed that curcumin intake affected hepatic lipid metabolism via the peroxisome proliferator-activated receptor (PPAR) pathway, especially PPARα activation, resulting in increased Apoa2 mRNA expression. The increase in liver weights was due to activation of PPARα and peroxisome proliferation. Taken together, these results demonstrate that curcumin is a PPARα activator and may affect expression levels of proteins involved in amyloid deposition to influence amyloidosis and metabolism in a complex manner.

APOA2: New Target for Molecular Hydrogen Therapy in Sepsis-Related Lung Injury Based on Proteomic and Genomic Analysis

“…This showed that the PPAR pathway is a potential target for hydrogen. The Apoa-II mRNA expression was increased through the activation of PPAR-α [39]. Therefore, Apoa2, as a link in the PPAR pathway, also has the potential to be a target of hydrogen.…”

Apolipoprotein A-II, a Player in Multiple Processes and Diseases

“…Recent studies showed that oxidative stress inhibitors (such as tempol and apocynin) reduced apoA-II amyloid deposition [132]. Contrary to expectations, via activation of the PPARα pathway, curcumin increased apoA-II amyloid deposition in mice that were induced to develop systemic amyloidosis [135].…”